Login |
Towards validated assays for key immunological outcomesTo highlight the importance of assay harmonisation in malaria vaccine development, the OPTIMALVAC Consortium has published the position paper “Towards validated assays for key immunological outcomes”. Vaccine 29 (2011) 3093–3095. OPTIMALVAC Annual Meeting 02 + 03 May 2011, Heidelberg, GermanyThe OPTIMALVAC Consortium convened for its yearly meeting on 02 + 03 May 2011 in Heidelberg, Germany. APPLY NOW - TRANSVAC CALL OPENThe fourth round of applications for access to the TRANSVAC infrastructure services is now closed. You can now apply for the next round with the Deadline 31 January 2012. The call will remain open for the duration of the project (until Sept 2013) or until all of the services have been exhausted. Applications will be processed in batches. The deadline for the next batch is 31 January 2012. Go to www.transvac.org for more info. OPTIMALVAC Kick-Off Meeting, 7-8 May 2009The OPTIMALVAC Kick-Off Meeting took place at the WHO building in Geneva on May 7-8, 2009.
Read the Final Minutes of the Meeting.
|
News
The European Vaccine Initiative is publishing a Press Release for the PRIMALVAC project, which aims at developing a vaccine to prevent Pregnancy Associated Malaria. There is currently a vacancy EVI for a Business Assistant, deadline for applications 7 September 2012 To read more about upcoming eventsplease go to ►Announcements. For information on past meetingsplease go to ►Meetings.
|
